ATE271390T1 - Verwendung von azithromycin zur topischen behandlung von augeninfektionen - Google Patents

Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Info

Publication number: ATE271390T1
Authority: AT; Austria
Prior art keywords: azithromycin; topical treatment; eye infections; treatment; infections
Prior art date: 1997-12-02

Application number

AT98309274T

Other languages

English (en)

Inventor

Imran Ahmed

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-02

Filing date

1998-11-12

Publication date

2004-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-11-12 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-08-15 Application granted granted Critical

2004-08-15 Publication of ATE271390T1 publication Critical patent/ATE271390T1/de

Links

208000001860 Eye Infections Diseases 0.000 title abstract 2
MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 2
229960004099 azithromycin Drugs 0.000 title abstract 2
230000000699 topical effect Effects 0.000 title abstract 2
208000011323 eye infectious disease Diseases 0.000 title 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

AT98309274T 1997-12-02 1998-11-12 Verwendung von azithromycin zur topischen behandlung von augeninfektionen ATE271390T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6725097P	1997-12-02	1997-12-02

Publications (1)

Publication Number	Publication Date
ATE271390T1 true ATE271390T1 (de)	2004-08-15

Family

ID=22074743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98309274T ATE271390T1 (de)	1997-12-02	1998-11-12	Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Country Status (11)

Country	Link
EP (1)	EP0925789B2 (de)
JP (1)	JPH11240838A (de)
AT (1)	ATE271390T1 (de)
BR (1)	BR9805318A (de)
CA (1)	CA2254682C (de)
CY (1)	CY1105482T1 (de)
DE (1)	DE69825128T3 (de)
DK (1)	DK0925789T4 (de)
ES (1)	ES2221127T5 (de)
MX (1)	MX232591B (de)
PT (1)	PT925789E (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6861411B1 (en)	1997-12-02	2005-03-01	Pfizer, Inc.	Method of treating eye infections with azithromycin
US7056893B2 (en)	1999-03-31	2006-06-06	Insite Vision, Inc.	Topical treatment for prevention of ocular infections
US6239113B1 (en)	1999-03-31	2001-05-29	Insite Vision, Incorporated	Topical treatment or prevention of ocular infections
IT1313610B1 (it) *	1999-08-09	2002-09-09	S I F I Societa Ind Farmaceuti	Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de)	2000-02-15	2001-08-23	Disetronic Licensing Ag	Zweikomponentiger Kolbenstopfen
EP1563850A3 (de) *	2000-02-23	2008-02-20	Pfizer Products Inc.	Verfahren zur Erhöhung der Bioverfügbarkeit und dem Eindringen in Gefässe von Azithromycin
IL141438A0 (en) *	2000-02-23	2002-03-10	Pfizer Prod Inc	Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr)	2001-04-12	2004-09-10	Thea Lab	Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1671979B1 (de)	2001-05-22	2008-08-13	Pfizer Products Inc.	Neue Kristallforme von Azithromycin
US7807802B2 (en)	2002-11-12	2010-10-05	Abbott Lab	Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
US6984403B2 (en)	2003-12-04	2006-01-10	Pfizer Inc.	Azithromycin dosage forms with reduced side effects
CA2549225A1 (en)	2003-12-04	2005-06-16	Pfizer Products Inc.	Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
JP2007513139A (ja)	2003-12-04	2007-05-24	ファイザー・プロダクツ・インク	安定性の改善した多粒子組成物
WO2005053652A1 (en)	2003-12-04	2005-06-16	Pfizer Products Inc.	Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513145A (ja)	2003-12-04	2007-05-24	ファイザー・プロダクツ・インク	医薬用多微粒子の製造方法
WO2006004085A1 (ja)	2004-07-02	2006-01-12	Wakamoto Pharmaceutical Co., Ltd.	アジスロマイシン含有水性医薬組成物及びその調製方法
US20060046970A1 (en) *	2004-08-31	2006-03-02	Insite Vision Incorporated	Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) *	2005-04-22	2009-08-21	Thea Sa Lab	Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) *	2005-12-28	2007-07-05	Wakamoto Pharmaceutical Co., Ltd.	水性医薬組成物
US9775802B2 (en)	2009-03-24	2017-10-03	Bausch & Lomb Incorporated	Method for preparing suspensions of low-solubility materials
US20100247666A1 (en) *	2009-03-24	2010-09-30	Macleod Steven K	Method for Preparing Suspensions of Low-Solubility Materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
EP0721324A1 (de) *	1993-10-01	1996-07-17	The Procter & Gamble Company	Verwendung von azithromycin zur behandlung von paradontose bei erwachsenen und topische zubereitungen für die verwendung
US5610198A (en) †	1994-03-18	1997-03-11	The United States Of America As Represented By The Department Of Health And Human Services	Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) *	1994-12-19	1996-07-10	Russinsky Limited	Compounds
US5872104A (en) *	1994-12-27	1999-02-16	Oridigm Corporation	Combinations and methods for reducing antimicrobial resistance
DE69634277T2 (de) †	1995-06-07	2006-01-05	Southern Biosystems, Inc., Birmingham	Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität

1998
- 1998-11-12 AT AT98309274T patent/ATE271390T1/de active
- 1998-11-12 DE DE69825128T patent/DE69825128T3/de not_active Expired - Lifetime
- 1998-11-12 EP EP98309274A patent/EP0925789B2/de not_active Expired - Lifetime
- 1998-11-12 DK DK98309274T patent/DK0925789T4/da active
- 1998-11-12 PT PT98309274T patent/PT925789E/pt unknown
- 1998-11-12 ES ES98309274T patent/ES2221127T5/es not_active Expired - Lifetime
- 1998-11-30 CA CA002254682A patent/CA2254682C/en not_active Expired - Lifetime
- 1998-11-30 BR BR9805318-3A patent/BR9805318A/pt not_active Application Discontinuation
- 1998-11-30 JP JP10339587A patent/JPH11240838A/ja active Pending
- 1998-12-01 MX MX9810124A patent/MX232591B/es active IP Right Grant
2004
- 2004-09-03 CY CY20041101028T patent/CY1105482T1/el unknown

Also Published As

Publication number	Publication date
DE69825128T3 (de)	2010-05-06
EP0925789B1 (de)	2004-07-21
ES2221127T5 (es)	2009-11-10
PT925789E (pt)	2004-10-29
CA2254682C (en)	2003-07-08
DE69825128T2 (de)	2005-07-28
JPH11240838A (ja)	1999-09-07
CA2254682A1 (en)	1999-06-02
MX232591B (es)	2005-12-02
EP0925789B2 (de)	2009-06-17
CY1105482T1 (el)	2010-04-28
DK0925789T3 (da)	2004-10-25
EP0925789A1 (de)	1999-06-30
DE69825128D1 (de)	2004-08-26
DK0925789T4 (da)	2009-07-13
ES2221127T3 (es)	2004-12-16
BR9805318A (pt)	2000-04-11

Legal Events

Date

Code

Title

Description

2005-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0925789

Country of ref document: EP

2009-11-15

UEP